Global Lung Cancer Liquid Biopsy Market to grow at a CAGR of 17.15% during the period 2017-2021

“The Report Global Lung Cancer Liquid Biopsy Market 2017-2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

​The main objective of this report is to define, describe, and forecast the global “Lung Cancer Liquid Biopsy” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges). It aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the market. The report attempts to forecast the market size for 5 major regions, namely, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It contains key vendor profiles and comprehensively analyzes their core competencies. The report also tracks and analyzes competitive developments, including partnerships, collaborations, acquisitions, new product developments, and R&D activities in the market.

Get Sample Copy Of This Report @​ https://www.marketresearchreports.biz/sample/sample/1476374 

About Lung Cancer Liquid Biopsy

A liquid biopsy helps to identify free-floating tumor DNA (also known as circulating DNA) within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. It is observed that the use of a liquid biopsy to identify carcinogenic cells of lungs will help in the early diagnosis of lung cancer.

Technavios analysts forecast the global lung cancer liquid biopsy market to grow at a CAGR of 17.15% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global lung cancer liquid biopsy market for 2017-2021. To calculate the market size, the report considers the sales and values of lung cancer liquid biopsy assays.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio’s report, Global Lung Cancer Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
QIAGEN

Request For TOC @ ​https://www.marketresearchreports.biz/reports/1476374/global-lung-cancer-liquid-biopsy-market-research-reports/toc 

Other prominent vendors
AccuraGen
Agena Bioscience
BARD1
BGI
Biodesix
Bio-Rad Laboratories
Cancer Genetics
CellMax Life
Circulogene
CLEARBRIDGE BIOMEDICS
Cynvenio Biosystems
EntroGen
Epic Sciences
Epigenomics
Fluxion Biosciences
Freenome
Gencurix
Genetracer Biotech
Genomic Health
Grail
Guardant Health
HeliTec
Inivata
Lonza
MedGenome
Nanoview Diagnostics
Natera
Novogene
OncoCyte
OncoDNA
Pathway Genomics
Personal Genome Diagnostics
Predicine
Shuwen Biotech
Sysmex
Thermo Fisher Scientific
Transgenomic
Trovagene

Request For Enquiry @ ​https://www.marketresearchreports.biz/sample/enquiry/1476374

Market driver
Rising incidence of lung cancer
For a full, detailed list, view our report

Market challenge
High cost of lab testing procedure
For a full, detailed list, view our report

Market trend
Vendors’ focus on clinical trials
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
Market outline
PART 05: MARKET LANDSCAPE
Market ecosystem
Market segmentation analysis
PART 06: MARKET SIZING
Market definition
Market sizing 2016
Market size and forecast 2016-2021
PART 07: FIVE FORCES ANALYSIS

Check Discount @​ https://www.marketresearchreports.biz/sample/checkdiscount/1476374 

PART 08: MARKET SEGMENTATION BY PRODUCT
Segmentation by product
Comparison by product
Global lung cancer liquid biopsy market by CTCs and ctDNA
Global lung cancer liquid biopsy market by exosomes and RNA
Market opportunity by product
PART 09: MARKET SEGMENTATION BY END-USER
Segmentation by end-user
Market share by end-user
Clinical diagnostic laboratories
Hospitals and clinics
Physicians’ office laboratories
PART 10: REGIONAL LANDSCAPE
Geographical segmentation
Regional comparison
Lung cancer liquid biopsy market in Americas
Lung cancer liquid biopsy market in EMEA
Lung cancer liquid biopsy market in APAC
Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 13: MARKET TRENDS
Growing partnership agreements
Vendors’ focus on clinical trials
Application of liquid biopsy for personalized treatment
PART 14: VENDOR LANDSCAPE
Competitive landscape
PART 15: KEY VENDOR ANALYSIS
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
QIAGEN
Key companies to watch
Other prominent vendors

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: [email protected]



Reset Password